Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company creating new and exciting molecules for applications in neurodegenerative diseases (AD, PD, ALS), stroke, metabolic diseases, oncology and other disease areas with great unmet medical need.
Based on its proprietary Truebinding™ platform, TrueBinding has to date discovered over 6 novel drug targets and developed potentially game changing monoclon...
Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company creating new and exciting molecules for applications in neurodegenerative diseases (AD, PD, ALS), stroke, metabolic diseases, oncology and other disease areas with great unmet medical need.
Based on its proprietary Truebinding™ platform, TrueBinding has to date discovered over 6 novel drug targets and developed potentially game changing monoclonal antibody drugs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.